edejong
Joined 13 years ago
Karma
3,464
Submissions
899
Member since
Aug 16
Joined 13 years ago
Their key mistake.
The 0.1%-0.2% was just bad science, taking medians over countries with lagging statistics reports.
Where did you find 3.4%? Isn’t that an upper bound?
Monitoring, dashboarding and alerting should leverage other BI-class tooling.
From 2021: “Biological markers of brain injury, neuroinflammation and Alzheimer’s correlate strongly with the presence of neurological symptoms in COVID-19 patients.”
[1] https://aaic.alz.org/releases_2021/covid-19-cognitive-impact...
hnchat.com:QC6b1eMuHsLMnBE6wPaw